Rocket Pharmaceuticals, Inc. (RCKT) — Stock Score Summary

Rocket Pharmaceuticals, Inc. (RCKT) has a MoatMap StockRank of 19/100 based on Quality (32/100), Value (40/100), and Momentum (33/100) factor scores. The current signal is STRONG SELL. Rocket Pharmaceuticals is a clinical-stage biotech company with high cash burn and no established commercial moat, failing the Terry Smith quality filter.

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing gene therapies for rare, devastating pediatric diseases. Utilizing both ex vivo lentiviral vector (LVV) and in vivo adeno-associated virus (AAV) based gene therapy platforms, Rocket targets a range of primary immunodeficiencies and other genetic disorders. The company operates as a specialized player in the high-growth gene therapy space, aiming to deliver potentially curative treatments for severe unmet medical needs.

Key Financial Metrics

Price$2.65
Market Cap$330M
P/E (Forward)-2.59
Price/Book1.34
Return on Equity-64.4%
Return on Invested Capital-73.7%
Debt/Equity10.40
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-99M

Rocket Pharmaceuticals, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Rocket Pharmaceuticals, Inc.’s (RCKT) StockRank?
MoatMap’s StockRank for Rocket Pharmaceuticals, Inc. (RCKT) is 19/100, with a Strong Sell signal. It is a composite of Quality (32), Value (40), and Momentum (33) factor ranks across MoatMap’s 19,000+ stock universe.
Does Rocket Pharmaceuticals, Inc. have an economic moat?
Rocket Pharmaceuticals, Inc. (RCKT) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Rocket Pharmaceuticals, Inc. a buy, hold, or sell?
MoatMap’s current signal for Rocket Pharmaceuticals, Inc. (RCKT) is Strong Sell, based on a StockRank of 19/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Rocket Pharmaceuticals, Inc. in?
Rocket Pharmaceuticals, Inc. (RCKT) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksRCKT deep dive reportAI ChampionsHow we score stocksSense-check another stock